Novavax, Inc.
NasdaqGS:NVAX
$ 13.00
$-1.39 (-9.65%)
$ 13.00
$-1.39 (-9.65%)
End-of-day quote: 05/17/2024

NVAX: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
NYSE:JNJ
Johnson & Johnson
154.64 0% 0% 372,168.87 3.21% 2.71%
NYSE:MRK
Merck
131.19 -10.02% 3.18% 332,278.86 2.35% -19.03%
LSE:AZN
AstraZeneca PLC
121.10 18.89% 41.61% 187,733.46 2.01% 15.98%
NYSE:PFE
Pfizer
28.64 8.42% 38.65% 162,291.22 5.81% -9.31%
LSE:GSK
GSK
17.75 7.44% 23.26% 72,385.16 3.25% 0.79%
NasdaqGS:MRNA
Moderna
132.90 -,110.71% -,107.39% 50,932.56 0% 0%
TSE:4502
Takeda Pharmaceutical Company
4130.00 0% 0% 6,479,696.8 4.74% 0%
NasdaqGS:BNTX
BioNTech
90.61 0% 0% 21,836.15 0% 299.65%
NasdaqGS:DVAX
Dynavax Technologies
11.11 -98.5% -95.63% 1,524.55 0% 219.67%
NasdaqCM:VBIV
VBI Vaccines
0.63 0% 0% 18.27 0% 0%